Literature DB >> 25440230

Prevention of emergency physician migratory contamination in a cluster randomized trial to increase tissue plasminogen activator use in stroke (the INSTINCT trial).

Victoria C Weston1, William J Meurer2, Shirley M Frederiksen3, Allison K Fox4, Phillip A Scott5.   

Abstract

OBJECTIVES: Cluster randomized trials (CRTs) are increasingly used to evaluate quality improvement interventions aimed at health care providers. In trials testing emergency department (ED) interventions, migration of emergency physicians (EPs) between hospitals is an important concern, as contamination may affect both internal and external validity. We hypothesized that geographically isolating EDs would prevent migratory contamination in a CRT designed to increase ED delivery of tissue plasminogen activator (tPA) in stroke (the INSTINCT trial).
METHODS: INSTINCT was a prospective, cluster randomized, controlled trial. Twenty-four Michigan community hospitals were randomly selected in matched pairs for study. Contamination was defined at the cluster level, with substantial contamination defined a priori as greater than 10% of EPs affected. Nonadherence, total crossover (contamination+nonadherence), migration distance, and characteristics were determined.
RESULTS: Three hundred seven EPs were identified at all sites. Overall, 7 (2.3%) changed study sites. One moved between control sites, leaving 6 (2.0%) total crossovers. Of these, 2 (0.7%) moved from intervention to control (contamination); and 4 (1.3%) moved from control to intervention (nonadherence). Contamination was observed in 2 of 12 control sites, with 17% and 9% contamination of the total site EP workforce at follow-up, respectively. Average migration distance was 42 miles for all EPs moving in the study and 35 miles for EPs moving from intervention to control sites.
CONCLUSION: The mobile nature of EPs should be considered in the design of quality improvement CRTs. Increased reporting of contamination in CRTs is encouraged to clarify thresholds and facilitate CRT design.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25440230      PMCID: PMC4826763          DOI: 10.1016/j.ajem.2014.08.073

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  8 in total

Review 1.  Contamination in trials: is cluster randomisation the answer?

Authors:  D J Torgerson
Journal:  BMJ       Date:  2001-02-10

Review 2.  Design and analysis of group-randomized trials: a review of recent methodological developments.

Authors:  David M Murray; Sherri P Varnell; Jonathan L Blitstein
Journal:  Am J Public Health       Date:  2004-03       Impact factor: 9.308

3.  Cluster randomized controlled trials.

Authors:  Suezann Puffer; David J Torgerson; Judith Watson
Journal:  J Eval Clin Pract       Date:  2005-10       Impact factor: 2.431

Review 4.  Contamination in trials of educational interventions.

Authors:  M R Keogh-Brown; M O Bachmann; L Shepstone; C Hewitt; A Howe; C R Ramsay; F Song; J N V Miles; D J Torgerson; S Miles; D Elbourne; I Harvey; M J Campbell
Journal:  Health Technol Assess       Date:  2007-10       Impact factor: 4.014

5.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  J Clin Epidemiol       Date:  2008-04       Impact factor: 6.437

6.  Attitudes and beliefs of Michigan emergency physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) trial hospitals.

Authors:  Phillip A Scott; Zhenzhen Xu; William J Meurer; Shirley M Frederiksen; Mary N Haan; Michael W Westfall; Sandip U Kothari; Lewis B Morgenstern; John D Kalbfleisch
Journal:  Stroke       Date:  2010-08-12       Impact factor: 7.914

7.  A multilevel intervention to increase community hospital use of alteplase for acute stroke (INSTINCT): a cluster-randomised controlled trial.

Authors:  Phillip A Scott; William J Meurer; Shirley M Frederiksen; John D Kalbfleisch; Zhenzhen Xu; Mary N Haan; Robert Silbergleit; Lewis B Morgenstern
Journal:  Lancet Neurol       Date:  2012-12-21       Impact factor: 44.182

8.  The impact of emergency physician turnover on planning for prospective clinical trials.

Authors:  William J Meurer; Cemal B Sozener; Zhenzhen Xu; Shirley M Frederiksen; Allison M Kade; Michael Olgren; Sanford J Vieder; John D Kalbfleish; Phillip A Scott
Journal:  West J Emerg Med       Date:  2013-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.